As featured in this year's Oliver Wyman Health Innovation Journal, we examine the emerging sparks beginning to define the dimensions of a new healthcare industry.
As one of the fastest-rising categories of healthcare costs, pharmaceuticals need to develop a metric that explains pricing.
#OWHealth's @OliverWyman @tomecrobinson recently spoke with @CNBC on the what's next for #Amazon and #healthcare in… https://t.co/r7WHJ9XINi
RT @iHealthMgmt: "Most executives believe the number of #virtual visits will surpass the number of physical visits by 2025."- Santiago Dori…
The Best of #OWHealth: Here are this year's Top #Infographics of 2018! Topics include payer-provider partnerships,… https://t.co/fi0n79nxPR
RT @NavvisPopHealth: The podcast with Navvis Executive Officer Stuart Baker, MD and Jefferson College of Population Health Dean David Nash,…
RT @zwitterion1: #ArtificialInteligence #healthcare #digitalhealth #OWHealth @OWHealthEditor https://t.co/dwXTeePUIM
RT @MotifConsulting: In healthcare, will the power of data enable behavioral changes at an individual level? https://t.co/iMLP7JPhXh
New on #OWHealth: Executives driving machine learning-focused companies examine artificial intelligence’s untapped… https://t.co/DC4AtPvV1W
RT @AlignmentHealth: .@OWHealthEditor imagines the way the front door to #healthcare will shift in the next decade: https://t.co/p1M6d8ixlI …
RT @OliverWyman: Health Innovation Journal: Will drug choice be spared from consumer decisions? We explore the topic. Read more here > htt…
RT @AlignmentHealth: Most physicians are not using #telehealth, suggesting that technology required for wider adoption are cost-prohibitive…
